Last updated on November 2017

A Study to Evaluate the Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated Pain


Brief description of study

A Study to Evaluate the Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated Pain

Detailed Study Description

The purpose of this study is to evaluate the safety and effectiveness of an investigational medication for the management of moderate to severe endometriosis-associated pain and other endometriosis-related symptoms.

Clinical Study Identifier: TX2255

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Julie Prettyman

AdvanceMed Research
Lawrenceville, NJ USA
  Connect »